The Na+K+-ATPase Inhibitor Marinobufagenin and Early Cardiovascular Risk in Humans: a Review of Recent Evidence (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s11906-019-0942-y
PubMed Identifier: 30980225
Publication URI: http://europepmc.org/abstract/MED/30980225
Type: Journal Article/Review
Parent Publication: Current Hypertension Reports
Issue: 5
ISSN: 1522-6417